Skip to content
Review

Natural Sciences Dysregulation and Therapeutic Targeting of RNA Splicing Variants in Cancer

· 0 citations · 96 references

TL;DR

This review article scrutinizes the aberrations in RNA splicing linked to cancer and explores therapeutic endeavors directed at addressing mutations in RNA splicing.

View source

Similar papers

Review Open access Aug 2026

Alternative RNA Splicing in Cancer: Molecular Mechanisms, Functional Consequences, Biomarkers and Therapeutic Opportunities

This review integrates the molecular logic of splice-site selection with the cancer-specific mechanisms that perturb it, summarizes representative isoform switches across the hallmarks of cancer, evaluates emerging technologies and clinical biomarkers, and discusses the opportunities and constraints of translating spli...

Quan-You Wu, Kai Gui · 0 citations
Review Open access Aug 2026

RNA splicing in health and disease

This review describes how spliceosome assembly, splicing regulatory elements, splicing factors, epigenetic modifications, and post-transcriptional processes determine splice-site selection and suggests that safe clinical translation will require greater selectivity, reduced off-target toxicity, and preservation of esse...

Huining Huang, Yao Yu, Qian Zhou et al. · 0 citations
Open access Sep 2026

Splicing modulation as an emerging therapeutic strategy in cancer: molecular mechanisms, clinical development, and future perspectives.

Progress will require more selective splicing-directed modalities, pharmacodynamic biomarkers that measure splicing perturbation in the relevant tumor or blood compartment, longitudinal mapping of genetic and tumor cell-state plasticity-driven resistance, and biomarker-defined combination trials to support expansion fr...

Xinbate Jingele, Qinxinru Sun, Xiao-Yang Li et al. · 0 citations
Review Sep 2026

The splicing axis of aging: mechanisms and therapeutic opportunities.

Aging is characterized by progressive loss of molecular fidelity that compromises stem-cell function and tissue homeostasis. Aging transcriptomes show widespread disruption of RNA processing, including increased intron retention, cryptic splice-site usage, and altered RNA quality control. These changes arise from somat...

Sada Raza, Ankita Kumari, Maciej Cieśla · 0 citations
Review Open access Aug 2026

Alternative splicing dysregulation in CAG repeat expansion diseases.

Alternative splicing of RNA is a highly regulated process that increases the complexity of gene expression, with disruption of splicing leading to significant disruption of cellular function and, ultimately, disease. This spliceopathy is exemplified by myotonic dystrophy type 1, a CTG repeat expansion disease, where dy...

Asmer Aliyeva, J. D. Cleary, Hannah K. Shorrock et al. · 0 citations
Review Open access Sep 2026

Natural antisense transcripts: Biology, mechanisms, and therapeutic potential: An update

Endogenous RNA molecules called natural antisense transcripts (NATs) are produced from the complementary DNA strand of either non-coding or protein-coding genes. NATs are not byproducts of random transcription but rather important controllers of gene expression, according to mounting evidence. Antisense transcription h...

M. Priya, B. K. Manjunath, P. K. Karibasappa et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.